Vir Biotechnology

VIR

Rank 2724

Country USA

Exchange NASDAQ

Currency USD

Sector LIFE SCIENCES

Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Address 499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, CA, US

Vir Biotechnology - Key figures

Market cap 3.42 Billion

Revenue 2.33 Billion

Profit 590.74 Million

P/E Ratio 2.849

P/s Ratio 1.472

Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.

The company is headquartered in San Francisco, California.